Foramen ovale is an embryonic defect in the interatrial septum which allows passage of
oxygenated blood from the right atrium to the left atrium. 1, 2 In about 75% of the population …

Background There is an ongoing debate on the role of percutaneous closure of patent
foramen ovale (PFO) in preventing recurrent ischemic events in patients with cryptogenic …

Background The efficacy of closure of a patent foramen ovale (PFO) in the prevention of
recurrent stroke after cryptogenic stroke is uncertain. We investigated the effect of PFO …

Objectives: We sought to assess the safety and clinical efficacy of patent foramen ovale
(PFO) closure under fluoroscopic guidance only, without intraprocedural echocardiography …

Patent foramen ovale (PFO) has been implicated in the pathogenesis of cryptogenic stroke,
arterial desaturation, decompression illness, and migraine headache (MH). This study …

Objectives: To carry out long-term follow-up after percutaneous closure of patent foramen
ovale (PFO) in patients with cryptogenic stroke. Design: Prospective cohort study. Setting …

Objectives To compare residual shunt rate and complications associated with six different
devices used for PFO closure. Background Transcutaneous PFO closure is an effective …

Background PFO is more common in cases with cryptogenic stroke compared to cases with
no stroke or stroke of identified etiology. Several randomized controlled trials (RCTs) …

NOVEMBER 13, 2017: 2227–3 0 2228 meta-analysis of the earlier 3 randomized trials,
percutaneous PFO closure was superior to medical therapy for secondary prevention of …

Aims We report our experience with three generations of the Cardia patent foramen ovale
(PFO) occluder in patients with cryptogenic thrombo-embolic events (TE). Methods and …